Effects of decitabine on allogeneic immune reactions of donor lymphocyte infusion via activation of dendritic cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2162-3619
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Effects of decitabine on allogeneic immune reactions of donor lymphocyte infusion via activation of dendritic cells ; volume:9 ; number:1 ; day:3 ; month:9 ; year:2020 ; pages:1-11 ; date:12.2020
Experimental hematology & oncology ; 9, Heft 1 (3.9.2020), 1-11, 12.2020
- Urheber
-
Kwon, Yong-Rim
Kim, Hye Joung
Sohn, Min-Jung
Lim, Ji-Young
Park, Kyung-Shin
Lee, Seok
Chung, Nack-Gyun
Jeong, Dae-Chul
Min, Chang-Ki
Kim, Yoo-Jin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40164-020-00178-y
- URN
-
urn:nbn:de:101:1-2020102421451755443013
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kwon, Yong-Rim
- Kim, Hye Joung
- Sohn, Min-Jung
- Lim, Ji-Young
- Park, Kyung-Shin
- Lee, Seok
- Chung, Nack-Gyun
- Jeong, Dae-Chul
- Min, Chang-Ki
- Kim, Yoo-Jin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Combination of Donor Lymphocyte Infusion and Blinatumomab for B-Cell Lymphoblastic Lymphoma Relapse after Allogeneic Stem-Cell Transplantation
Alterations of peripheral blood T cell subsets following donor lymphocyte infusion in patients after allogeneic stem cell transplantation
Specific immunosuppression by postoperative intravenous infusion of allogeneic leukocytes
Feasibility, safety, and efficacy of early prophylactic donor lymphocyte infusion after T cell-depleted allogeneic stem cell transplantation in acute leukemia patients
Monitoring and characterization of T-lymphocyte reconstitution after allogeneic stem cell transplantation
Biomarkers for response to donor lymphocyte infusion after allogeneic stem cell transplantation in patients with acute myeloid leukemia
Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia
Venetoclax plus azacitidine and donor lymphocyte infusion in treating acute myeloid leukemia patients who relapse after allogeneic hematopoietic stem cell transplantation
Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia
Safety but limited efficacy of donor lymphocyte infusion for post-transplantation cyclophosphamide-treated patients
Allogeneic CD19-CAR-T cell infusion after allogeneic hematopoietic stem cell transplantation in B cell malignancies
Expression of decitabine-targeted oncogenes in meningiomas in vivo
Combination of Donor Lymphocyte Infusion and Blinatumomab for B-Cell Lymphoblastic Lymphoma Relapse after Allogeneic Stem-Cell Transplantation
Alterations of peripheral blood T cell subsets following donor lymphocyte infusion in patients after allogeneic stem cell transplantation
Specific immunosuppression by postoperative intravenous infusion of allogeneic leukocytes
Feasibility, safety, and efficacy of early prophylactic donor lymphocyte infusion after T cell-depleted allogeneic stem cell transplantation in acute leukemia patients
Monitoring and characterization of T-lymphocyte reconstitution after allogeneic stem cell transplantation
Biomarkers for response to donor lymphocyte infusion after allogeneic stem cell transplantation in patients with acute myeloid leukemia
Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia
Venetoclax plus azacitidine and donor lymphocyte infusion in treating acute myeloid leukemia patients who relapse after allogeneic hematopoietic stem cell transplantation
Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia
Safety but limited efficacy of donor lymphocyte infusion for post-transplantation cyclophosphamide-treated patients
Allogeneic CD19-CAR-T cell infusion after allogeneic hematopoietic stem cell transplantation in B cell malignancies
Expression of decitabine-targeted oncogenes in meningiomas in vivo
Combination of Donor Lymphocyte Infusion and Blinatumomab for B-Cell Lymphoblastic Lymphoma Relapse after Allogeneic Stem-Cell Transplantation
Alterations of peripheral blood T cell subsets following donor lymphocyte infusion in patients after allogeneic stem cell transplantation
Specific immunosuppression by postoperative intravenous infusion of allogeneic leukocytes
Feasibility, safety, and efficacy of early prophylactic donor lymphocyte infusion after T cell-depleted allogeneic stem cell transplantation in acute leukemia patients
Monitoring and characterization of T-lymphocyte reconstitution after allogeneic stem cell transplantation
Biomarkers for response to donor lymphocyte infusion after allogeneic stem cell transplantation in patients with acute myeloid leukemia
Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia
Venetoclax plus azacitidine and donor lymphocyte infusion in treating acute myeloid leukemia patients who relapse after allogeneic hematopoietic stem cell transplantation
Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia
Safety but limited efficacy of donor lymphocyte infusion for post-transplantation cyclophosphamide-treated patients
Allogeneic CD19-CAR-T cell infusion after allogeneic hematopoietic stem cell transplantation in B cell malignancies